Armin Schwarzbach, MD, PhD – Lyme Testing – 2022 Conference (LDN; low dose naltrexone)
Armin Schwarzbach, MD, PhD – Lyme Testing – 2022 Conference (LDN; low dose naltrexone)
Lyme Disease Market Report 2023-2033… (News)
Lyme Disease Market Report 2023-2033 | Industry Size, Growth and Latest Insights theyyscene.ca 08 August 2023 https://www.theyyscene.ca/lyme-disease-market-report-2023-2033-industry-size-growth-and-latest-insights/ The newly published report by IMARC Group, titled ”Lyme Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the lyme disease market. The increasing adoption of immunomodulatory therapies, including low-dose […]
LDN therapy hope for the desired pregnancy? (in Polish) (News)
LDN therapy hope for the desired pregnancy? (in Polish) (News) Medexpress.pl 05 February 2023 https://www.medexpress.pl/terapia-ldn-nadzieja-na-upragniona-ciaze/86337 Recently, there have been a number of scientific papers showing that low-dose naltrexone may help treat some chronic conditions, such as Crohn’s disease, ulcerative colitis, irritable bowel syndrome, chronic fatigue syndrome, long COVID, anxiety, and in poor sleep quality and […]
Clinicians Discuss Major Treatments for Long COVID–The Effective and the Questionable (News)
Clinicians Discuss Major Treatments for Long COVID–The Effective and the Questionable The Epoch Times 02 January 2023 https://www.theepochtimes.com/health/clinicians-discuss-major-treatments-for-long-covid-the-effective-and-the-questionable_4950709.html Long COVID is a syndrome rather than a disease due to its complicated symptoms like brain fog, fatigue, malaise, shortness of breath, tachycardia, and gastrointestinal problems, to name just a few. Depending on the symptoms and overall health […]
The LDN Book 3 (LDN; low dose naltrexone)
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details
Dosing of Low Dose Naltrexone (LDN)
Sleep Issues and Low Dose Naltrexone (LDN)
The Immune System and Low Dose Naltrexone (LDN)
Tim – England: Eye cancer (2022) (LDN; low dose naltrexone)
Tim – England: Eye cancer (2022) (LDN; low dose naltrexone) Approximately 12 years ago, Tim started to lose the vision in his left eye and was told he had an ocular tumor. He had 2-3 years of treatment, but had to undergo removal of the eye. Eight or nine years later he developed a […]
LDN Webinar 18 May 2022 (LDN; low dose naltrexone)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com